Allergy Therapeutics (OTCPK:AGYTF) Accumulated Depreciation

: $0.00 Mil (As of Jun. 2022)

View and export this data going back to 2004. Start your Free Trial

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Allergy Therapeutics's quarterly accumulated depreciation declined from Jun. 2021 ($-29.67 Mil) to Dec. 2021 ($0.00 Mil) but then stayed the same from Dec. 2021 ($0.00 Mil) to Jun. 2022 ($0.00 Mil).

Allergy Therapeutics's annual accumulated depreciation increased from Jun. 2020 ($-23.05 Mil) to Jun. 2021 ($-29.67 Mil) but then stayed the same from Jun. 2021 ($-29.67 Mil) to Jun. 2022 ($0.00 Mil).

Allergy Therapeutics Accumulated Depreciation Historical Data

The historical data trend for Allergy Therapeutics's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergy Therapeutics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Accumulated Depreciation

-19.28

-19.57

-23.05

-29.67

Allergy Therapeutics Semi-Annual Data
	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22
Accumulated Depreciation																-23.05	-	-29.67	-	-

Allergy Therapeutics Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Allergy Therapeutics Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Allergy Therapeutics's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Allergy Therapeutics (OTCPK:AGYTF) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergy Therapeutics PLC (OTCPK:AGYTF) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

AGY:UK HHU:Germany

Address

Dominion Way, Worthing, West Sussex, GBR, BN14 8SA

Website

http://www.allergytherapeutics.com

Allergy Therapeutics PLC is active in the healthcare sector in the United Kingdom. It is a pharmaceutical company mainly engaged in the treatment and prevention of allergy with aluminium-free products. The company's geographical segment includes Central Europe; Southern Europe and the Rest of the World. It generates maximum revenue from Central Europe which includes Germany and other countries.

Allergy Therapeutics (OTCPK:AGYTF) Headlines

No Headlines